Skip to main content
Caplight Logo









Tagomics Ltd.

Tagomics Ltd.

Private
CambridgeHealthcare & Life Scienceshttps://tagomics.com/

Last Round

Series A

Feb 21, 2024

Total Funding Raised

$10.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Tagomics Ltd. is a biotechnology company that develops a multiomic profiling platform for biomarker discovery and disease diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

multiomic profilingliquid biopsybiomarker discoveryepigenomic sequencingcancer diagnosticsfragmentomicsprecision medicineearly cancer detectionbioinformaticsgenomicsmultiomicsclinical researchnext-gen sequencingngsbiotech r&d

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tagomics Ltd. Comparables

Compare Tagomics Ltd. with similar companies based on industry and business-model similarity.

Tagomics Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Precede Biosciences
81%
biomodal
81%
ClearNote Health
79%

Tagomics Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 21, 2024
Pre SeedDec 1, 2021

Key People

Founding team and executive leadership

Jack Kennefick

Co-founder, Director and Chief Executive Officer

Founding Team

Debora Lucarelli

Chief Technology Officer

Executive Team

Tagomics Ltd. Investors

Notable investors and investment history

Tagomics Ltd. investors
InvestorRounds
Start CodonPre Seed
Agilent VenturesSeries A
OMX VenturesSeries A
IQ CapitalSeries A, Pre Seed
Innovate UKPre Seed
Calculus CapitalSeries A
Mercia VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2026

    Grew 23% QoQ, from 22 to 27 employees.

  • Feb 14, 2025

    Grew 24% QoQ from 17 to 21 employees.

Tagomics Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tagomics Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tagomics Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range27
Year Founded2020
Last FundingFeb 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?